Analogs of hirudin having anti-platelet activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 15, 514 12, 530327, 530324, A61K 3800, C07K 500, C07K 700

Patent

active

055740120

ABSTRACT:
This invention relates to peptide derivatives which are useful anticoagulant agents.

REFERENCES:
patent: 4668662 (1987-05-01), Tripier
patent: 4767742 (1988-08-01), Dodt et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4971953 (1990-11-01), Krstenansky
patent: 5192745 (1993-03-01), Krstenansky et al.
patent: 5192747 (1993-03-01), Krstenansky
patent: 5232912 (1993-08-01), Krstenansky et al.
patent: 5236898 (1993-08-01), Krstenansky et al.
patent: 5279812 (1994-01-01), Krstenansky et al.
Pierschbacker et al., J. of Biol Chem., vol. 262, No. 26, pp. 17294-17298, 1987.
Lam et al., J. of Biol. Chem., vol. 262, No. 3, pp. 947-950, 1987.
Maraganore et al, J. of Biol Chem., vol. 264, No. 15, pp. 8692-8698, 1989.
The Merck Manual, Thirteenth Edition (1977), pp. 302-308.
The Merck Manual, Thirteenth Edition (1977), pp. 606-608.
The Merck Manual, Thirteenth Edition (1977), pp. 1926-1927.
Hoffmann A. et al., "Inhibition of the Thrombin-Platelet Reaction by Hirudin" Haemostasis 14:164-169 (1984).
Markwardt F. et al., "Comparative Studies on Thrombin Inhibitors in Experimental Microthrombosis". Thrombosis and Haemostasis (Stuttgart 49 (3) 235-237 (1983).
Church et al., "Chimeric Antithrombin Peptide," J. Biol. Chem., vol. 266, No. 18, pp. 11975-11979 (1991).
Krstenansky, et al., "Development of MDL 28,050, a Small Stable Antithrombin Agent Based on a Functional Domain of the Leech Protein, Hirudin," Thromb. Haem. vol. 63 (2):208-214 (1990).
Krstenansky, et al., "C-Terminal Peptide Alcohol, Acid and Amide Analogs of Desulfato Hirudin 54-65 as Antithrombin Agents," Thromb. Research 54:319-325 (1989).
Krstenansky, et al., "Anticoagulant Peptides: Nature of the Interaction of the C-Terminal Region of Hirudin with a Noncatalytic Binding Site on Thrombin," J. Med. Chem. 30:1688-1691 (1987).
Chemical Abstract 109:231560t p. 918 (1988) abstracting Krstenansky, et al., "Preparation of hirudin segments as anticoagulants," EP Appl 276,014.
Krstenansky, et al., "Comparison of Hirudin and Hirudin PA C-Terminal Fragments and Related Analogs as Antithrombin Agents," Thromb. Research, vol. 52(2):137-141 (1988).
Krstenansky, et al., "Antithrombin Properties of C-terminus of Hirudin using Synthetic unsulfated N-acetyl-hirudin 45-65," FEBS Lett. 211(1) 10-16 (1987).
Bajusz, et al., "Thrombin Inhibition by Hirudin Fragments: Possible Mechanism of Hirudin-Thromein Interaction," Peptides 32:473-476 (1984).
Dodt, et al., "The complete amino acid sequence of hirudin, a thrombin specific inhibitor," FEBS Letters 165(2), 180-84 (1984).
Owen, et al., "N-Terminal Requirements of Small Peptide Anticoagulants Based on Hirudin 54-65," J. Med. Chem., 31, 1009-1011 (1988).
Krstenansky, et al., "Characterization of the Interaction of Thrombin with the Carboxyl-terminal Region of the Leech Anticoagulant Peptide Hirudin," Peptides: Chemistry and Biology, 1987, pp. 447-448.
Minar, et al., abstract of "Local Hirudin Application," Klin Wochenschr 63(4): 190-1 (1985).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Analogs of hirudin having anti-platelet activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Analogs of hirudin having anti-platelet activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs of hirudin having anti-platelet activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-562561

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.